top of page

NEWS AND EVENTS
Breakfast Meetings
Monthly breakfast meetings are hosted on our Teams channel, and recordings of previous meetings are also available. Log in here.
Not a member? Request membership by contacting us.
Blog
Search


'DNA Repair in Urological Malignancies' - a breakfast meeting with Robert Hanson
Robert Hanson, a PhD student in Charlie Massey's lab is studying prostate cancer and developing markers of response and resistance to DNA...

Carley Batley
May 6, 20213 min read
224 views
0 comments


University of Cambridge Professor Evis Sala launches cancer screening AI start-up Lucida Medical.
Co-founders Professor Sala and Dr Antony Rix have developed cancer screening AI software using radiogenomics, machine learning and image...

Carley Batley
Apr 20, 20212 min read
262 views
0 comments


You can help Addenbrooke's buy a surgical robot
Urological Malignancies Lead Professor Grant Stewart is one of five clinicians featured in a new fundraising campaign by Addenbrooke's...

Carley Batley
Apr 13, 20211 min read
53 views
0 comments


ARTIST study recruits over 100 participants in first 60 days
ARTIST (a translational research Approach to development of optimal Renal cancer Treatments In Surgical and systemic Therapy patients)...

Carley Batley
Mar 25, 20212 min read
100 views
0 comments


Cambridge-led kidney cancer screening trial to start in Leeds
A new study, led by researchers at the University of Cambridge, will investigate the feasibility of developing a full kidney cancer screenin

Carley Batley
Feb 24, 20212 min read
121 views
0 comments


Professor Grant Stewart presents NAXIVA results at ASCO GU 2021
UM programme lead Grant Stewart presented the findings of our NAXIVA study in a five-minute rapid abstract session at ASCO GU 2021.

Carley Batley
Feb 17, 20212 min read
92 views
0 comments
European research group RECUR aims to build evidence base for effective RCC follow-up
RECUR is the EuRopEan association of urology renal cell carcinoma guidelines panel Collaborative multicenter consortium for the studies...

Carley Batley
Nov 24, 20203 min read
157 views
0 comments


New research demonstrates the power of genome sequencing for understanding childhood cancer
Urological Malignancies programme member Dr. Tom Mitchell explains the groundbreaking findings in his recently published NEJM paper on...

Dr. Tom Mitchell
Nov 17, 20202 min read
111 views
0 comments


New research finds public enthusiastic about kidney cancer screening
In this guest blog, Laragh Harvey-Kelly, a final-year medical student at the University of Cambridge, explains her recently published...

Laragh Harvey-Kelly
Nov 11, 20203 min read
112 views
0 comments


Urological Malignancies programme member Dr. James Jones takes clinical lectureship
The Urological Malignancies programme congratulates Dr. James Jones on this new milestone in his career.

Carley Batley
Oct 27, 20202 min read
598 views
0 comments


Active observation remains the best care for kidney cancer patients after surgery
A recently published trial by Urological Malignancies programme member Professor Tim Eisen of the University of Cambridge, concluded that...

Tim Eisen
Oct 15, 20201 min read
19 views
0 comments


Urological Malignancies Programme award moves biomarker research forward
"Mitochondrial ctDNA could add considerably to number of targets available for ctDNA-based assays."

Dr. Christopher Smith
Oct 14, 20203 min read
19 views
0 comments
Current evidence on screening for renal cancer
New paper examines evidence for screening of renal cell carcinoma. Juliet Usher-Smith, Rebecca K. Simmons, Sabrina H. Rossi and Grant D....

Professor Grant Stewart
Sep 8, 20202 min read
189 views
1 comment
Earliest genetic roots of childhood kidney cancer uncovered
Members of the Cambridge Renal Cancer consortium have contributed to a fundamental discovery of how Wilm's tumour, the childhood renal...
Sarah Burge
Dec 20, 20191 min read
16 views
0 comments
bottom of page